BackOnconova Therapeutics Overview

Onconova Therapeutics Other Current Liabilities

Latest other current liabilities for ONTX: $5.5M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$5.54M

Peer trimmed avg / median

Loading

Onconova Therapeutics Other Current Liabilities History

Loading

Onconova Therapeutics vs. peers: Other Current Liabilities Comparison

Loading

Onconova Therapeutics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Onconova Therapeutics (ONTX) FAQ

Onconova Therapeutics (ONTX) currently reports a other current liabilities of $5.5M as of March 2026. Use the charts on this page to explore Onconova Therapeutics's other current liabilities history and peer comparisons.

Onconova Therapeutics reported $5.5M in other current liabilities as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $5.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Onconova Therapeutics, and consider following ONTX for alerts when major investors trade the stock.

Onconova Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $5.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONTX with unrelated industries.